glp 1 drugs heart failure Impact of glp-1 receptor agonists on hospitalization for and all-cause death in patients with diabetes with and without heart failure: a real-world study | Clinical Research in Cardiology GLP-1s Reduced Adverse Heart Failure
Description
Espinosa, Enith
The glucagon component adds a dimension of metabolic activation that the other compounds simply do not possess
Further supporting a cardiometabolic role of GLP-1 (9-36amide), both GLP-1 (7-36amide) and GLP-1 (9-36amide), but not exendin-4, promote vasodilation in isolated and ex vivo cultured mesenteric blood vessels [201], i.e., the vasodilatory effect of GLP-1 (7-36amide) was not different relative to that of GLP-1 (9-36amide) and was likewise preserved in GLP-1R KO mice [201]
April 2026: As of April 1, there are now 73 pending cases in MDL 3163, which involves vision loss (non-arteritic anterior ischemic optic neuropathy) cases filed by people taking GLP-1 drugs, including Zepbound
diabetes 2019;68
GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management
